Neuroendocrine control of ovulation
- PMID: 22283375
- DOI: 10.3109/09513590.2012.651929
Neuroendocrine control of ovulation
Abstract
Modern methods of diagnosis have made the distinction between hypothalamic failure and ovarian failure routine. Failure of the orderly progression of hypothalamic gonadotrophin-releasing hormone (GnRH) → pituitary gonadotrophins → ovarian steroids and inhibin → hypothalamus/pituitary results in anovulation/amenorrhea. The hypothalamic connections that regulate the pattern and amplitude of GnRH pulses are plastic and respond to external/psychological conditions and internal/metabolic factors that may affect the hypothalamic substrate on which estrogen levels can act. We trace the neuroendocrine regulation of the ovarian cycle, concentrating on hypothalamic connections that underlie negative and positive feedback control of GnRH and the complementary role of the adenohypophysis. The main hormone regulating this "central axis" and the development of the endometrium is estradiol which is exported from the developing ovarian follicles and thereby closes the feedback loop with follicle development. Progesterone and inhibin are also involved. Neuroendocrine responses to internal and external factors can cause anovulation and amenorrhea. Generally, these are accompanied by abnormal negative feedback between estradiol and the gonadotrophins; coexistence of low estradiol and luteinizing hormone/follicle-stimulating hormone. There are three main causes: (1) genetic diseases that interfere with the migration of GnRH cells into the brain or result in misfolding of GnRH; (2) input from the brain that interrupts normal feedback (e.g. stress and weight loss amenorrhea); and (3) the effect of agents which alter central neurotransmission and hypothalamic function (e.g. elevated prolactin and psychotropic medications). All types of hypothalamic insufficiency result in insufficient stimulation of the ovaries. In addition to amenorrhea, this central alteration also results in other complications (downstream disease) that make hypothalamic amenorrhea of greater consequence than simply reproductive failure. Thus, there may be more at stake in the diagnosis and treatment of hypothalamic failure than brings the patient to her caregiver.
Similar articles
-
Estrogen-induced hypothalamic synaptic plasticity and pituitary sensitization in the control of the estrogen-induced gonadotrophin surge.Reprod Sci. 2007 Feb;14(2):101-16. doi: 10.1177/1933719107301059. Reprod Sci. 2007. PMID: 17636222 Review.
-
[Patients with functional hypothalamic amenorrhea are characterized by low serum inhibin B concentrations].Pol Merkur Lekarski. 2010 May;28(167):350-3. Pol Merkur Lekarski. 2010. PMID: 20568395 Polish.
-
Pituitary and ovarian response to acute stimulation with LH-RH in normal and anovulatory women.Int J Fertil. 1977;22(1):6-15. Int J Fertil. 1977. PMID: 18416
-
The neuroendocrine regulation of the human ovarian cycle.Chronobiol Int. 2001 Nov;18(6):893-919. Chronobiol Int. 2001. PMID: 11777079 Review.
-
The endocrine basis of infertility in women.Nurs Clin North Am. 1980 Sep;15(3):511-24. Nurs Clin North Am. 1980. PMID: 6777763
Cited by
-
Prolonged Amenorrhea and Resumption of Menses in Women with HIV.J Womens Health (Larchmt). 2018 Sep 14;27(12):1441-8. doi: 10.1089/jwh.2018.7046. Online ahead of print. J Womens Health (Larchmt). 2018. PMID: 30222490 Free PMC article.
-
Enrichment of ovine gonadotropes via adenovirus gene targeting enhances assessment of transcriptional changes in response to estradiol-17 beta†.Biol Reprod. 2020 Feb 12;102(1):156-169. doi: 10.1093/biolre/ioz166. Biol Reprod. 2020. PMID: 31504222 Free PMC article.
-
COVID-19-associated mental health impact on menstruation physiology: A survey study among medical students in Jordan.Womens Health (Lond). 2023 Jan-Dec;19:17455057221150099. doi: 10.1177/17455057221150099. Womens Health (Lond). 2023. PMID: 36714969 Free PMC article.
-
Introduction to Environmental Harmful Factors.Adv Exp Med Biol. 2021;1300:3-19. doi: 10.1007/978-981-33-4187-6_1. Adv Exp Med Biol. 2021. PMID: 33523427
-
Use of Vitex agnus-castus in patients with menstrual cycle disorders: a single-center retrospective longitudinal cohort study.Arch Gynecol Obstet. 2024 May;309(5):2089-2098. doi: 10.1007/s00404-023-07363-4. Epub 2024 Feb 23. Arch Gynecol Obstet. 2024. PMID: 38393671 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources